XML 63 R57.htm IDEA: XBRL DOCUMENT
v3.25.2

Balance Sheet Components (Additional Information) (Details) - La Jolla Pharmaceutical Company - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended |
--- | --- | --- | ---
Jun. 30, 2025 | Jun. 30, 2024 | Jun. 30, 2025 | Jun. 30, 2024 | Dec. 31, 2024
Inventory [Line Items] |  |  |  |  |
Net fair value adjustment of inventory from acquisition | $ 8.5 |  | $ 8.5 |  | $ 9.2
Amortization of fair value adjustments of Cost of products sold | $ 0.4 | $ 3.5 | $ 0.6 | $ 10.3 |

X
- Definition Amortization of fair value adjustments of cost of products sold. + References No definition available. + Details
Name: | inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold
Namespace Prefix: | inva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Value of net fair value adjustment of inventory resulting from the acquisition. + References No definition available. + Details
Name: | inva_FairValueAdjustmentsOfInventoryFromAcquistion
Namespace Prefix: | inva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_InventoryLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_LaJollaPharmaceuticalCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |